![](https://www.diabetesnews.com/wp-content/uploads/2013/11/20061210_debiotech01-150x150.jpg)
People with diabetes would be injected under the skin with ultra-small insulin-carrying nanoparticles. The porous particles leak insulin that forms a reservoir that is contained by the particles’ electrostatic properties. Until the insulin is needed, that electrostatic force prevents it from entering the bloodstream.
Read more